edrecolomab
rituximab
trastuzumab
gemtuzumab ozogamicin
cetuximab
bevacizumab
panitumumab
catumaxomab
ofatumumab
ipilimumab
brentuximab vedotin
pertuzumab
trastuzumab emtansine
obinutuzumab
dinutuximab beta
nivolumab
pembrolizumab
blinatumomab
ramucirumab
noncytumumab
elotuzumab
daratumumab
mogamulizumab
inotuzumab ozogamicin
olaratumab
durvalumab
bermekimab
avelumab
atezolizumab
cemiplimab
moxetumomab pasudotox
tafasitamab
enfortumab vedotin
polatuzumab vedotin
isatuximab
belantamab mafodotina
dostarlimab
trastuzumab drukstecan
altri farmaci antineoplastici